Dr Raj Vikesh Tiwari, Associate Consultant, Department of Urology at Sengkang General Hospital (SKH), answers your questions on how prostate cancer is screened for, diagnosed and what active surveillance entails.
Prostate Cancer Doctor Q&A
Prostate cancer is fast becoming one of the most common cancers affecting Singaporean men as our population ages.
With improved diagnostic techniques including more prevalent use of PSA (Prostate-Specific Antigen) tests, multi parametric MRI scans of the prostate and targeted prostate biopsies, this has led to an increase in the number of cases. However most prostate cancers are low risk, which carries minimal impact on patient survival.
As November marks the month to raise awareness for men's health issues, Dr Raj Vikesh Tiwari, Associate Consultant for the
Department of Urology at
Sengkang General Hospital (SKH), a member of the
SingHealth group, will answer your queries about
prostate cancer screening, diagnosis and treatment.
Simply email your questions to
Please note: Your question will go live/appear on our
forum page when the doctor answers it.
This Ask the Specialist forum is open from
1 November to 26 November 2018.
Dr Raj Vikesh Tiwari
Dr Raj Vikesh Tiwari is an Associate Consultant with the Department of Urology at Sengkang General Hospital (SKH), with a special interest in urologic cancers and benign prostate hyperplasia. He graduated from the National University of Singapore, Yong Loo Lin School of Medicine in 2009 and attained membership of the Royal College of Surgeons of Edinburgh in 2012. He completed his urology residency training at Singapore General Hospital in 2018.
He is currently practising in SKH and is also an adjunct research fellow at DUKE-NUS graduate medical school. He also contributes to undergraduate and postgraduate medical education.